BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33772152)

  • 21. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
    Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort.
    Nelson RL; Turyk M; Kim J; Persky V
    BMC Cancer; 2002 Sep; 2(1):22. PubMed ID: 12377099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States.
    Arnold M; Freisling H; Stolzenberg-Solomon R; Kee F; O'Doherty MG; Ordóñez-Mena JM; Wilsgaard T; May AM; Bueno-de-Mesquita HB; Tjønneland A; Orfanos P; Trichopoulou A; Boffetta P; Bray F; Jenab M; Soerjomataram I;
    Eur J Epidemiol; 2016 Sep; 31(9):893-904. PubMed ID: 27300353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study.
    Lai GY; Park Y; Hartge P; Hollenbeck AR; Freedman ND
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E497-502. PubMed ID: 23408570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Yang K; Doege D; Thong MSY; Koch-Gallenkamp L; Weisser L; Bertram H; Eberle A; Holleczek B; Nennecke A; Waldmann A; Zeissig SR; Pritzkuleit R; Jansen L; Brenner H; Arndt V
    Cancer; 2024 Apr; 130(7):1158-1170. PubMed ID: 37996981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
    Ordóñez-Mena JM; Schöttker B; Mons U; Jenab M; Freisling H; Bueno-de-Mesquita B; O'Doherty MG; Scott A; Kee F; Stricker BH; Hofman A; de Keyser CE; Ruiter R; Söderberg S; Jousilahti P; Kuulasmaa K; Freedman ND; Wilsgaard T; de Groot LC; Kampman E; Håkansson N; Orsini N; Wolk A; Nilsson LM; Tjønneland A; Pająk A; Malyutina S; Kubínová R; Tamosiunas A; Bobak M; Katsoulis M; Orfanos P; Boffetta P; Trichopoulou A; Brenner H;
    BMC Med; 2016 Apr; 14():62. PubMed ID: 27044418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of diabetes care in breast, colorectal, and prostate cancer.
    Griffiths RI; McFadden EC; Stevens RJ; Valderas JM; Lavery BA; Khan NF; Keating NL; Bankhead CR
    J Cancer Surviv; 2018 Dec; 12(6):803-812. PubMed ID: 30291561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burden of Cancer in a Large Consortium of Prospective Cohorts in Europe.
    Tsilidis KK; Papadimitriou N; Capothanassi D; Bamia C; Benetou V; Jenab M; Freisling H; Kee F; Nelen A; O'Doherty MG; Scott A; Soerjomataram I; Tjønneland A; May AM; Ramón Quirós J; Pettersson-Kymmer U; Brenner H; Schöttker B; Ordóñez-Mena JM; Karina Dieffenbach A; Eriksson S; Bøgeberg Mathiesen E; Njølstad I; Siganos G; Wilsgaard T; Boffetta P; Trichopoulos D; Trichopoulou A
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27154917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediating effects of cancer risk factors on the association between race and cancer incidence: analysis of the NIH-AARP Diet and Health Study.
    Akinyemiju T; Moore JX; Pisu M
    Ann Epidemiol; 2018 Jan; 28(1):33-40.e2. PubMed ID: 29217211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
    JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.
    Lopez DS; Malagaris I; Polychronopoulou E; Tsilidis KK; Milani SA; Kristen Peek M; Villasante-Tezanos A; Alzweri L; Baillargeon J; Kuo YF; Canfield S
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):792-803. PubMed ID: 35902376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Prediagnostic Frailty, Change in Frailty Status, and Mortality After Cancer Diagnosis in the Women's Health Initiative.
    Cespedes Feliciano EM; Hohensee C; Rosko AE; Anderson GL; Paskett ED; Zaslavsky O; Wallace RB; Caan BJ
    JAMA Netw Open; 2020 Sep; 3(9):e2016747. PubMed ID: 32926116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General supplement use, subsequent use and cancer risk in the UK Women's Cohort Study.
    Hutchinson J; Burley VJ; Greenwood DC; Cade JE
    Eur J Clin Nutr; 2014 Oct; 68(10):1095-100. PubMed ID: 24801368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
    Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight change and cancer risk in a cohort of more than 65,000 adults in Austria.
    Rapp K; Klenk J; Ulmer H; Concin H; Diem G; Oberaigner W; Schroeder J
    Ann Oncol; 2008 Apr; 19(4):641-8. PubMed ID: 18056917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes, obesity, and subsequent risk of postmenopausal breast cancer among white and black women in the Southern Community Cohort Study.
    Sanderson M; Lipworth L; Shrubsole MJ; Andersen SW; Shu XO; Zheng W; Hargreaves MK; Blot WJ
    Cancer Causes Control; 2019 May; 30(5):425-433. PubMed ID: 30941541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia.
    Rossi E; Hung J; Beilby JP; Knuiman MW; Divitini ML; Bartholomew H
    Ann Epidemiol; 2006 Mar; 16(3):206-12. PubMed ID: 16343942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.